Stay updated on PF 06838435 Hemophilia B Clinical Trial
Sign up to get notified when there's something new on the PF 06838435 Hemophilia B Clinical Trial page.

Latest updates to the PF 06838435 Hemophilia B Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference0.4%

- Check28 days agoChange DetectedThe footer now identifies the site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe site footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedThe hemophilia B trial is now listed as terminated early rather than completed. The sponsor says participants may transition to a long-term follow-up study and that the decision was not based on safety or efficacy concerns.SummaryDifference0.4%

- Check55 days agoChange DetectedA new revision label v3.7.0 was added to the record history and the previous revision v3.6.6 was removed.SummaryDifference0.1%

Stay in the know with updates to PF 06838435 Hemophilia B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF 06838435 Hemophilia B Clinical Trial page.